| Nancy Kay Dorau, PT | |
|
6640 Johnson Dr, Mission, KS 66202-2617 | |
| (913) 384-5810 | |
| (913) 384-0719 |
| Full Name | Nancy Kay Dorau |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 38 Years |
| Location | 6640 Johnson Dr, Mission, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124161575 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2019026487 (Missouri) | Secondary |
| 225100000X | Physical Therapist | 11-06224 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Serc Rehabilitation Partners Llc | 9830344563 | 195 |
| Serc Rehabilitation Partners Llc | 9830344563 | 195 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
The Hong Kong Polytechnic University has achieved a breakthrough in the cancer genomics by developing a novel big data analysis platform for analyzing the interactions among genes. The analysis platform unveils the unregulated patterns of gene network in cancer and discovers potential diagnostic and therapeutic target genes, Nucleophosmin (NPM1) and its associated genes, in Chronic Myelogenous Leukemia (CML).
W. L. Gore & Associates today announced that the Food and Drug Administration has granted indication for the GORE VIABAHN Endoprosthesis to treat stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous access grafts.
The dyslexic brain may have a general problem forming perceptual categories, including the templates for printed letters and speech sounds, say University of Southern California (USC) neuroscientists.
› Verified 3 days ago
| Provider Name | Serc Rehabilitation Partners Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1760745244 PECOS PAC ID: 9830344563 Enrollment ID: O20130517000516 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
The Hong Kong Polytechnic University has achieved a breakthrough in the cancer genomics by developing a novel big data analysis platform for analyzing the interactions among genes. The analysis platform unveils the unregulated patterns of gene network in cancer and discovers potential diagnostic and therapeutic target genes, Nucleophosmin (NPM1) and its associated genes, in Chronic Myelogenous Leukemia (CML).
W. L. Gore & Associates today announced that the Food and Drug Administration has granted indication for the GORE VIABAHN Endoprosthesis to treat stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous access grafts.
The dyslexic brain may have a general problem forming perceptual categories, including the templates for printed letters and speech sounds, say University of Southern California (USC) neuroscientists.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nancy Kay Dorau, PT 1200 Corporate Dr Ste 400, Hoover, AL 35242-5424 Ph: (423) 238-7217 | Nancy Kay Dorau, PT 6640 Johnson Dr, Mission, KS 66202-2617 Ph: (913) 384-5810 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.
Kidney transplants that show a combination of fibrosis (scarring) and inflammation after one year are at higher risk of long-term transplant failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
The Hong Kong Polytechnic University has achieved a breakthrough in the cancer genomics by developing a novel big data analysis platform for analyzing the interactions among genes. The analysis platform unveils the unregulated patterns of gene network in cancer and discovers potential diagnostic and therapeutic target genes, Nucleophosmin (NPM1) and its associated genes, in Chronic Myelogenous Leukemia (CML).
W. L. Gore & Associates today announced that the Food and Drug Administration has granted indication for the GORE VIABAHN Endoprosthesis to treat stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous access grafts.
The dyslexic brain may have a general problem forming perceptual categories, including the templates for printed letters and speech sounds, say University of Southern California (USC) neuroscientists.
› Verified 3 days ago
Michael A Sabolovic, M.S.P.T., M.T.C. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5799 Broadmoor St, Suite 300, Mission, KS 66202 Phone: 913-384-5600 Fax: 913-384-0719 | |
Julia Nicole Beausoleil, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6640 Johnson Dr, Mission, KS 66202 Phone: 913-384-5810 Fax: 913-384-0719 | |
Mr. Larry J Estes, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5350 W 61st Place, Mission Springs, Mission, KS 66205 Phone: 913-262-8070 Fax: 913-262-8070 | |
Mary Jo Hegstrom, PT, BSPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6640 Johnson Dr, Mission, KS 66202 Phone: 913-384-5810 Fax: 913-384-0719 | |
Elizabeth A Daze, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6640 Johnson Dr, Mission, KS 66202 Phone: 913-384-5810 Fax: 913-384-0719 | |
Kansas City Physical Therapy Group Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5799 Broadmoor St, Ste 300, Mission, KS 66202 Phone: 913-384-5600 |